Condition
Narcotic-Related Disorders
Total Trials
7
Recruiting
2
Active
6
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 7 trials
Late-Stage Pipeline
29%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (1)
P 3 (2)
Trial Status
Active Not Recruiting4
Recruiting2
Enrolling By Invitation1
Clinical Trials (7)
Showing 7 of 7 trials
NCT06810076Not ApplicableActive Not Recruiting
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
NCT05577026Not ApplicableActive Not Recruiting
Safe Prescription of Opioids in Primary Care
NCT06387290Phase 3Recruiting
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
NCT06008990Active Not Recruiting
Maternal Brain Imaging in Opioid Use Disorder
NCT06023459Phase 3Active Not Recruiting
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
NCT06548490Phase 2Recruiting
GLP-1R Agonist Treatment for Opioid Use Disorder
NCT06415994Enrolling By Invitation
Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder
Showing all 7 trials